Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hypertonic saline in preschool children with cystic fibrosis
ACTRN12615001067561Phase 3Completed
- Sponsor
- Kids Research Institute Australia
- Start
- Nov 2017
- Modality
- Small Molecules
- Countries
- 7
01
Overview
Phase 3, randomised, double-blind trial of hypertonic saline in cystic fibrosis (CF) (2 arms), sponsored by Kids Research Institute Australia. Primary endpoint: Difference in PRAGMA-CF %Dis score at 48 weeks. Started Nov 2017; status: completed.
02
Drugs
hypertonic saline
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on ACTRN12615001067561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615001067561.